Chan Zou, Xiaocong Zuo, Jie Huang, Ye Hua, Shuang Yang, Xiaoyan Yang, . . . Guoping Yang. (2019). Phase I Trial of Pyragrel, a Novel Thromboxane Synthetase Inhibitor, to Evaluate the Safety, Tolerability, and Pharmacokinetics in Healthy Volunteers. Frontiers Media S.A..
Chicago Style (17th ed.) CitationChan Zou, et al. Phase I Trial of Pyragrel, a Novel Thromboxane Synthetase Inhibitor, to Evaluate the Safety, Tolerability, and Pharmacokinetics in Healthy Volunteers. Frontiers Media S.A., 2019.
MLA (9th ed.) CitationChan Zou, et al. Phase I Trial of Pyragrel, a Novel Thromboxane Synthetase Inhibitor, to Evaluate the Safety, Tolerability, and Pharmacokinetics in Healthy Volunteers. Frontiers Media S.A., 2019.
Warning: These citations may not always be 100% accurate.